In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Oumayma KoukiLR18ES03, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, Faculty of Science of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
Mohamed Montassar LasramLR18ES03, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, Faculty of Science of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
Amel AbidiLR18ES03, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, Faculty of Science of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
Jérôme LeprinceLaboratory of Neuroendocrine, Endocrine and Germinal Differentiation and Communication (NorDiC), Inserm UMR 1239, University Rouen Normandie, 76000 Rouen, France.ORCID 0000-0002-7814-9927 Imen GhzaielClermont Auvergne National Polytechnic Institute, INP, French National Centre for Scientific Research, Institut Pascal, University Clermont Auvergne, 63001 Clermont-Ferrand, France.ORCID 0000-0001-8181-9445 John J MackrillDepartment of Physiology, University College Cork, Western Gateway Building, Western Road, T12 XF62 Cork, Ireland.ORCID 0000-0003-2473-129X Taoufik GhrairiLR18ES03, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, Faculty of Science of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.ORCID 0000-0002-9937-0858 Gérard LizardLaboratoire Interdisciplinaire Carnot de Bourgogne ICB UMR 6303 (Team Prof. N. Millot), French National Center for Scientific Research (CNRS), Inserm, University Bourgogne Europe, 21000 Dijon, France.ORCID 0000-0001-6330-0172 Olfa Masmoudi-KoukiLR18ES03, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, Faculty of Science of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.ORCID 0000-0001-8062-6561 Funding
Horizon-Marie Skłodowska-Curie Actions (MSCA) RISE PsyCoMed Project 10108624PHC-Utique 22G0809/47608VJPHC-Utique 24G0807/50283RD
6 · The paper itselfAbstract
Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Although cisplatin is widely used in chemotherapy, its clinical efficacy is often limited by adverse effects and resistance. Thus, natural bioactive compounds are gaining attention as complementary therapeutic agents. This study aimed to evaluate the anti-tumor effects of
Indexed as
AnnonaAntineoplastic AgentsCisplatinPlant ExtractsPlant LeavesTriple Negative Breast NeoplasmsAnimalsApoptosisAutophagyCell Line, TumorDrug SynergismFemaleGene Expression Regulation, NeoplasticHumansMiceSignal TransductionAntineoplastic AgentsCisplatinPlant ExtractsTOR Serine-Threonine KinasesAnnona muricata aqueous leaf extractapoptosisautophagycisplatinsynergetic anticancertriple-negative breast cancer cell line
Identifiers
PMID41677580
PMCPMC12896402
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390